CRIS: Curis, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,117.45
Enterprise Value ($M) 957.84
Book Value ($M) 130.67
Book Value / Share 1.43
Price / Book 8.31
NCAV ($M) 99.06
NCAV / Share 1.08
Price / NCAV 11.28

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.85
Return on Equity (ROE) 0.88

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 17.14

Balance Sheet (mrq) ($M)
Current Assets 172.75
Assets 204.36
Liabilities 73.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -24.90
Net Income -29.90
Earnings Per Share Basic And Diluted -0.61
Earnings Per Share Diluted -0.61
Earnings Per Share Basic -0.61

Cash Flow Statement (mra) ($M)
Cash From Operations -25.70
Cash from Investing -49.05
Cash from Financing -49.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-22 13G Point72 Asset Management, L.P. 5.80
02-16 13G Sio Capital Management, LLC 5.78
02-16 13G Ra Capital Management, L.p. 8.50
02-11 13G/A Biotechnology Value Fund L P -82.82
02-01 13G Adage Capital Partners Gp, L.l.c. 5.49
01-06 13G/A Sabby Management, Llc 0.00 -100.00
2020-02-14 13G/A EcoR1 Capital, LLC 0.00 -100.00
2019-01-09 13G/A First Eagle Investment Management, LLC 1.35 0.00
2018-07-10 13G/A BlackRock Inc. 2.40 -91.72
2018-01-10 13G/A Fmr Llc 4.39 -51.11
2016-09-13 13G/A Aurigene Discovery Technologies Ltd 19.60
2014-02-12 13G/A Vanguard Group Inc 3.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-03-16 10-K Annual Report – 10-K
2020-08-04 10-Q Quarterly Report – 10-Q
2020-05-12 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-04-13 359,565 1,789,508 20.09
2021-04-12 303,875 1,754,646 17.32

(click for more detail)

(click for list of largest short owners)

Similar Companies
CPRX – Catalyst Pharmaceuticals Inc CRBP – Corbus Pharmaceuticals Holdings Inc
CRDF – Cardiff Oncology Inc CRMD – CorMedix Inc.
CRNX – Crinetics Pharmaceuticals Inc


Financial data and stock pages provided by
Fintel.io


Finpedia: Curis